APIC BIO Trademark

Trademark Overview

On Thursday, January 3, 2019, a trademark application was filed for APIC BIO with the United States Patent and Trademark Office. The USPTO has given the APIC BIO trademark a serial number of 88249082. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 30, 2023. This trademark is owned by Apic Bio, Inc.. The APIC BIO trademark is filed in the Pharmaceutical Products category with the following description:

Preparations for use in the treatment of autosomal dominant disorders; pharmaceutical preparations, namely, preparations for use in the treatment of rare diseases; pharmaceutical preparations, namely, preparations for use in the treatment of congenital diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, preparations for use in the treatment of Alpha-1 Antitrypsin Deficiency; biological preparations for use in the treatment of autosomal dominant disorders, rare diseases, congenital diseases, Amyotrophic Lateral Sclerosis (ALS), and Alpha-1 Antitrypsin Deficiency; gene therapy products for use in the treatment of autosomal dominant disorders, rare diseases, congenital diseases, Amyotrophic Lateral Sclerosis (ALS), and Alpha-1 Antitrypsin Deficiency
apic bio

General Information

Serial Number88249082
Word MarkAPIC BIO
Filing DateThursday, January 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2019

Trademark Statements

Goods and ServicesPreparations for use in the treatment of autosomal dominant disorders; pharmaceutical preparations, namely, preparations for use in the treatment of rare diseases; pharmaceutical preparations, namely, preparations for use in the treatment of congenital diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, preparations for use in the treatment of Alpha-1 Antitrypsin Deficiency; biological preparations for use in the treatment of autosomal dominant disorders, rare diseases, congenital diseases, Amyotrophic Lateral Sclerosis (ALS), and Alpha-1 Antitrypsin Deficiency; gene therapy products for use in the treatment of autosomal dominant disorders, rare diseases, congenital diseases, Amyotrophic Lateral Sclerosis (ALS), and Alpha-1 Antitrypsin Deficiency
Disclaimer with Predetermined Text"BIO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameApic Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameApic Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, January 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 30, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2022SOU EXTENSION 5 GRANTED
Thursday, June 23, 2022SOU EXTENSION 5 FILED
Thursday, June 23, 2022TEAS EXTENSION RECEIVED
Tuesday, December 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 17, 2021SOU EXTENSION 4 GRANTED
Friday, December 17, 2021SOU EXTENSION 4 FILED
Friday, December 17, 2021TEAS EXTENSION RECEIVED
Wednesday, June 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021SOU EXTENSION 3 GRANTED
Monday, June 21, 2021SOU EXTENSION 3 FILED
Monday, June 21, 2021TEAS EXTENSION RECEIVED
Tuesday, December 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 18, 2020SOU EXTENSION 2 GRANTED
Friday, December 18, 2020SOU EXTENSION 2 FILED
Friday, December 18, 2020TEAS EXTENSION RECEIVED
Saturday, July 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 18, 2020CORRECTED NOA E-MAILED
Friday, July 17, 2020SOU EXTENSION 1 GRANTED
Monday, June 22, 2020SOU EXTENSION 1 FILED
Friday, July 17, 2020DIVISIONAL PROCESSING COMPLETE
Monday, June 22, 2020DIVISIONAL REQUEST RECEIVED
Friday, July 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 22, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, June 22, 2020TEAS EXTENSION RECEIVED
Tuesday, December 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 17, 2019ASSIGNED TO LIE
Wednesday, September 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NON-FINAL ACTION WRITTEN
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Friday, January 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 7, 2019NEW APPLICATION ENTERED

Related Keywords

apic preparations treatment diseases namely pharmaceutical sclerosis alpha deficiency antitrypsin lateral